Intercept Pharm (ICPT) Reports Q4 Loss of $2.02
Get Alerts ICPT Hot Sheet
Join SI Premium – FREE
Intercept Pharm (NASDAQ: ICPT) reported Q4 EPS of ($2.02), versus ($1.32) reported last year.
For earnings history and earnings-related data on Intercept Pharm (ICPT) click here.
For earnings history and earnings-related data on Intercept Pharm (ICPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- The post-earnings selloff has created a buying opportunity in this stock - Argus
- The Blackstone Group (BX) PT Raised to $135 at Argus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!